We are live on ! Find out more
LMAT icon

LeMaitre Vascular

143 hedge funds and large institutions have $395M invested in LeMaitre Vascular in 2017 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 48 increasing their positions, 47 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

322% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 9

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

37% more capital invested

Capital invested by funds: $288M → $395M (+$107M)

25% more funds holding

Funds holding: 114143 (+29)

4.58% more ownership

Funds ownership: 62.65%67.23% (+4.6%)

2% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 47

Holders
143
Holders Change
+29
Holders Change %
+25.44%
% of All Funds
3.57%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
38
Increased
48
Reduced
47
Closed
9
Calls
$3K
Puts
Net Calls
+$3K
Net Calls Change
-$46K
Name Holding Trade Value Shares
Change
Change in
Stake
JWA
151
JFS Wealth Advisors
Pennsylvania
-$25K -1,000 Closed
TRCT
152
Tower Research Capital (TRC)
New York
-$2K -100 Closed

LMAT Hedge Fund Activity: Q2 2017 in Review

143 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q2 2017, worth a combined $395M — up 37% from $288M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new LMAT positions and 9 closed out — a net gain of 29 holders — while 48 added to existing stakes and 47 trimmed.

The largest buyer was BlackRock, adding an estimated $22.6M. The largest seller was Columbia Wanger Asset Management, cutting an estimated $23.8M.

  • 143 institutional investors held LeMaitre Vascular (LMAT) as of Q2 2017, up from 114 in Q1 2017.
  • Funds reported $395M of LeMaitre Vascular stock for Q2 2017, up 37% quarter-over-quarter.
  • 38 funds opened new LeMaitre Vascular positions in Q2 2017 and 9 closed out, a net change of +29 holders.
  • The largest LeMaitre Vascular buyer in Q2 2017 was BlackRock, an estimated $22.6M added.
  • The largest LeMaitre Vascular seller in Q2 2017 was Columbia Wanger Asset Management, an estimated $23.8M sold.

Based on aggregated 13F filings for Q2 2017.